EileenMSegretiMD

Obstetrics & Gynecology • Pittsburgh, PA

Gynecologic Oncology

Obstetrician-gynecologist in Pittsburgh, Pennsylvania and is affiliated with multiple hospitals in the area, including Heritage Valley Health System-Beaver and West Penn Hospital

Join to view full profile

Dr. Segreti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Segreti's full profile

Already have an account?

Office
4815 Liberty Ave
suite 310
Pittsburgh, PA 15224
Phone+1 412-578-1116
Is this information wrong?

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 1992 - 1994
McGaw Medical Center of Northwestern UniversityResidency, Obstetrics and Gynecology, 1988 - 1992
Duke University School of MedicineClass of 1988

Certifications & Licensure

PA State Medical License 2003 - 2024
VA State Medical License 1994 - 2006
TX State Medical License 1992 - 1994
IL State Medical License 1988 - 1993
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
Fellow (FACS) American College of Surgeons

Clinical Trials

Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer Start of enrollment: 2005 Mar 21
Active, not recruiting
Phase 3
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer Start of enrollment: 2009 Apr 01
Completed
Phase 3
Collecting Tumor Samples From Patients With Gynecological Tumors Start of enrollment: 1992 Jun 01
Completed
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer Start of enrollment: 2009 Jun 29
Active, not recruiting
Phase 3
Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Jan 19
Active, not recruiting
Not Applicable
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma Start of enrollment: 2009 Nov 01
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

8 citations
Long-term local control and survival after concomitant boost accelerated radiotherapy for locally advanced cervix cancer.
Brian D. Kavanagh, Eileen M. Segreti, Derrick Koo, Cyrus Amir, Douglas W. Arthur, John B. Wheelock, Robert M. Cardinale, Rupert Schmidt-Ullrich> ;American Journal of Clinical Oncology. 2001 Apr 1
2 citations
Gynecologic brachytherapy: digital fluoroscopy for placement verification and treatment planning.
Brian D. Kavanagh, Robert D. Zwicker, Eileen M. Segreti, Leo A. Lindquist, Ann S. Fulcher, Gina M. Hundley, John A. Spindler, Robert M. Cardinale> ;Radiology. 2000 Jun 1
17 citations
Cost analysis of erythropoietin versus blood transfusions for cervical cancer patients receiving chemoradiotherapy.
Brian D. Kavanagh, Bernard A Fischer, Eileen M. Segreti, John B. Wheelock, Cecilia Boardman, Susan D. Roseff, Robert M. Cardinale, Stanley H Benedict, Adrian L Goram> ;International Journal of Radiation Oncology, Biology, Physics. 2000 Jan 1
60 citations
Recurrent Cervical Carcinoma: Typical and Atypical Manifestations
Ann S. Fulcher, Susan G. O'Sullivan, Eileen M. Segreti, Brian D. Kavanagh> ;Radiographics. 1999 Oct 1
31 citations
Hepatocyte growth factor (HGF) induces invasion of endometrial carcinoma cell lines in vitro.
Victoria Bae-Jump, Eileen M. Segreti, David T. Vandermolen, Scott W. Kauma> ;Gynecologic Oncology. 1999 May 1
21 citations
A pilot study of concomitant boost accelerated superfractionated radiotherapy for stage III cancer of the uterine cervix
Brian D. Kavanagh, Holger L. Gieschen, Rupert Schmidt-Ullrich, Douglas W. Arthur, Robert D. Zwicker, Nathan Kaufman, Dean R. Goplerud, Eileen M. Segreti, Randal J. West> ;International Journal of Radiation Oncology, Biology, Physics. 1997 Jun 1
17 citations
Transverse Colon Urinary Diversion in Gynecologic Oncology
Eileen M. Segreti, Mitchell Morris, Charles F Levenback, Kristin R. Lucas, David M. Gershenson, Thomas W. Burke> ;Gynecologic Oncology. 1996 Oct 1
15 citations
A comparison of end and loop colostomy for fecal diversion in gynecologic patients with colonic fistulas.
Eileen M. Segreti, Charles F Levenback, Mitchell Morris, Kristin R. Lucas, David M. Gershenson, Thomas W. Burke> ;Gynecologic Oncology. 1996 Jan 1
7 citations
Successful Percutaneous Drainage of Gluteal Pyomyositis Occurring after Intra-arterial Chemotherapy and Pelvic Irradiation
Eileen M. Segreti, Adnan Munkarah, Charles F Levenback> ;Gynecologic Oncology. 1994 Jun 1
12 citations
Estrogen and progesterone receptor content of endometrial carcinomas: comparison of total tissue versus cancer component analysis.
John T. Soper, Eileen M. Segreti, Debra B. Novotny, David G. Mutch, William T. Creasman, Kenneth S. McCarty> ;Gynecologic Oncology. 1990 Mar 1
21 citations
Endometrial cancer: Histologic correlates of immunohistochemical localization of progesterone receptor and estrogen receptor
Eileen M. Segreti, Debra B. Novotny, John T. Soper, David G. Mutch, William T. Creasman, Kenneth S. McCarty> ;Obstetrics and Gynecology. 1989 Jan 1
Join now to see all